Concepts and epidemiology of spondyloarthritis

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 3, 2006, Pages 401-417

  Sieper, Joachim ^a   Rudwaleit, Martin ^a   Khan, Muhammed Asim ^b   Braun, Jürgen ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c RHEUMAZENTRUM RUHRGEBIET   (Germany)

Author keywords

early diagnosis; HLA B27; prevalence; spondyloarthritides

Indexed keywords

HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ANTIBODY;

ANKYLOSING SPONDYLITIS; ARTHRITIS; CHRONIC PAIN; CLINICAL FEATURE; CORRELATION FUNCTION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERITIS; HUMAN; INCIDENCE; LEG DISEASE; LOW BACK PAIN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REVIEW; SPONDYLITIS; SPONDYLOARTHROPATHY; SYMPTOMATOLOGY; TREATMENT PLANNING;

EARLY DIAGNOSIS; FEMALE; HLA-B27 ANTIGEN; HUMANS; INCIDENCE; MALE; PREVALENCE; SPONDYLARTHROPATHIES;

EID: 33744910087     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.02.001     Document Type: Review

References (80)

1. Moll J.M., Haslock I., Macrae I.F., and Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore) 53 (1974) 343-364
2. Braun J., and Sieper J. Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the international workshop on new treatment strategies in ankylosing spondylitis, Berlin, Germany, 18-19 January 2002. Annals of the Rheumatic Diseases 61 supplement 3 (2002) iii61-iii67
3. Dougados M., van der Linden S., Juhlin R., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis and Rheumatism 34 (1991) 1218-1227
4. Sieper J., Braun J., and Kingsley G.H. Report on the fourth international workshop on reactive arthritis. Arthritis and Rheumatism 43 (2000) 720-734
5. Leirisalo-Repo M., Helenius P., Hannu T., et al. Long-term prognosis of reactive salmonella arthritis. Annals of the Rheumatic Diseases 56 (1997) 516-520
6. Sieper J., Fendler C., Laitko S., et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis and Rheumatism 42 (1999) 1386-1396
7. Mannoja A., Pekkola J., Hamalainen M., et al. Lumbosacral radiographic signs in patients with previous enteroarthritis or uroarthritis. Annals of the Rheumatic Diseases 64 (2005) 936-939
8. Leirisalo-Repo M. & Sieper J. Reactive spondyloarthrtis: epidemiology, clinical features and treatment. In van der Heijde D & Weizman M (eds.) Ankylosing Spondylitis. Philadelphia: Elsevier; 2006; p. 53-64.
9. Gladman D.D. Psoriatic arthritis. Rheumatic Diseases Clinics of North America 24 (1998) 829-844 [x]
10. Moll J.M., and Wright V. Psoriatic arthritis. Seminars in Arthritis and Rheumatism 3 (1973) 55-78
11. Helliwell P.S., and Taylor W.J. Classification and diagnostic criteria for psoriatic arthritis. Annals of the Rheumatic Diseases 64 supplement 2 (2005) ii3-ii8
12. Zochling J., Brandt J., and Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 44 (2005) 1483-1491
13. Orchard T.R., Thiyagaraja S., Welsh K.I., et al. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118 (2000) 274-278
14. De Vos M., Cuvelier C., Mielants H., et al. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 96 (1989) 339-344
15. Purrmann J., Zeidler H., Bertrams J., et al. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27, B44. The Journal of Rheumatology 15 (1988) 1658-1661
16. Braun J., Bollow M., Remlinger G., et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis and Rheumatism 41 (1998) 58-67
17. Kellgren J.H. Diagnostic criteria for population studies. Bulletin on the Rheumatic Diseases 13 (1962) 291-292
18. Gofton J.P., Lawrence J.S., Bennett P.H., and Burch T.A. Sacro-ilitis in eight populations. Annals of the Rheumatic Diseases 25 (1966) 528-533
19. Bennett P.H., and Burch T.A. Population Studies of the Rheumatic Diseases (1968), Excerpta Medica Foundation, Amsterdam p. 456-7
20. Krebs W. Das Röntgenbild des Beckens bei der Bechterewschen Krankheit. Fortschritte auf dem Gebiete der Rontgenstrahlen 50 (1934) 537
21. van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis and Rheumatism 27 (1984) 361-368
22. Mau W., Zeidler H., Mau R., et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. The Journal of Rheumatology 15 (1988) 1109-1114
23. Rudwaleit M., Khan M.A., and Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?. Arthritis and Rheumatism 52 (2005) 1000-1008
24. Braun J., Bollow M., Eggens U., et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis and Rheumatism 37 (1994) 1039-1045
25. Feldtkeller E., Khan M.A., van der Heijde D., et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatology International 23 (2003) 61-66
26. van der Linden S., and van der Heijde D. Ankylosing spondylitis. Clinical features. Rheumatic Diseases Clinics of North America 24 (1998) 663-676 [vii]
27. Sieper J. & Rudwaleit M. How early should ankylosing spondylitis be treated with tumour necrosis factor blockers? Annals of the Rheumatic Diseases; 2005; 64(Suppl 4): 61-64.
28. Braun J., Brandt J., Listing J., et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359 (2002) 1187-1193
29. Davis Jr. J.C., Van Der Heijde D., Braun J., et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis and Rheumatism 48 (2003) 3230-3236
30. Haibel H. Rudwaleit M. Brandt HC et al. Adalimumab reduces spinal symptoms in active ankylosing spondylitis-clinical and MRI results of a 52 weeks open label trial. Arthritis and Rheumatism; 2006; 54: 678-681.
31. Wanders A., Heijde D., Landewe R., et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis and Rheumatism 52 (2005) 1756-1765
32. Amor B., Dougados M., Listrat V., et al. Are classification criteria for spondylarthropathy useful as diagnostic criteria?. Revue du Rhumatisme England Edition 62 (1995) 10-15
33. Boyer G.S., Templin D.W., and Goring W.P. Evaluation of the European Spondylarthropathy Study Group preliminary classification criteria in Alaskan Eskimo populations. Arthritis and Rheumatism 36 (1993) 534-538
34. Collantes-Estevez E., Cisnal del Mazo A., and Munoz-Gomariz E. Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European Spondylarthropathy Study Group. The Journal of Rheumatology 22 (1995) 246-251
35. van Tubergen A., Heuft-Dorenbosch L., Schulpen G., et al. Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?. Annals of the Rheumatic Diseases 62 (2003) 519-525
36. Underwood M.R., and Dawes P. Inflammatory back pain in primary care. British Journal of Rheumatology 34 (1995) 1074-1077
37. Rudwaleit M., van der Heijde D., Khan M.A., et al. How to diagnose axial spondyloarthritis early. Annals of the Rheumatic Diseases 63 (2004) 535-543
38. Grimes D.A., and Schulz K.F. Refining clinical diagnosis with likelihood ratios. Lancet 365 (2005) 1500-1505
39. Calin A., Porta J., Fries J.F., and Schurman D.J. Clinical history as a screening test for ankylosing spondylitis. JMMA 237 (1977) 2613-2614
40. Rudwaleit M. Metter A. Lisitng J. et al., Inflammatory back pain in ankylosing spondylitis-a reassessment of the clinical history for classification and for diagnosis. Arthritis and Rheumatism; 2006; 54: 569-578.
41. Sieper J., Rudwaleit M., Braun J., and van der Heijde D. Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis and Rheumatism 46 (2002) 319-327
42. van der Heijde D., Bellamy N., Calin A., et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in ankylosing spondylitis working group. The Journal of Rheumatology 24 (1997) 2225-2229
43. Russel M.G., and Stockbrugger R.W. Epidemiology of inflammatory bowel disease: an update. Scandinavian Journal of Gastroenterology 31 (1996) 417-427
44. Akkoc N., and Khan M.A. Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In: Weisman M.H., Reveille J.D., and van der Heijde D. (Eds). Ankylosing Spondylitis and the Spondyloarthropathies (2005), Mosby, London 117-131
45. Bakland G., Nossent H.C., and Gran J.T. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis and Rheumatism 53 (2005) 850-855
46. Bhatia K., Prasad M.L., Barnish G., and Koki G. Antigen and haplotype frequencies at three human leucocyte antigen loci (HLA-A, -B, -C) in the Pawaia of Papua New Guinea. American Journal of Physical Anthropology 75 (1988) 329-340
47. Krylov M., Erdesz S., Alexeeva L., et al. HLA class II and HLA-B27 oligotyping in two Siberian native population groups. Tissue Antigens 46 (1995) 382-386
48. Alexeeva L., Krylov M., Vturin V., et al. Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia. The Journal of Rheumatology 21 (1994) 2298-2300
49. Khan M.A., Braun W.E., Kushner I., et al. HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians. The Journal of Rheumatology 3 supplement (1977) 39-43
50. Khan M.A. HLA-B27 and its subtypes in world populations. Current Opinion in Rheumatology 7 (1995) 263-269
51. Calin A., and Fries J.F. Striking prevalence of ankylosing spondylitis in 'healthy' w27 positive males and females. The New England Journal of Medicine 293 (1975) 835-839
52. Cohen L.M., Mittal K.K., Schmid F.R., et al. Increased risk for spondylitis stigmata in apparently healthy HLA-W27 men. Annals of Internal Medicine 84 (1976) 1-7
53. Christiansen F.T., Hawkins B.R., Dawkins R.L., et al. The prevalence of ankylosing spondylitis among B27 positive normal individuals-a reassessment. The Journal of Rheumatology 6 (1979) 713-718
54. Braun J., Listing J., and Sieper J. Reply. Arthritis and Rheumatism 52 (2005) 4049-4050
55. van der Linden S.M., Valkenburg H.A., de Jongh B.M., and Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis and Rheumatism 27 (1984) 241-249
56. Saraux A., Guillemin F., Guggenbuhl P., et al. Prevalence of spondyloarthropathies in France: 2001. Annals of the Rheumatic Diseases 64 (2005) 1431-1435
57. Johnsen K., Gran J.T., Dale K., and Husby G. The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). The Journal of Rheumatology 19 (1992) 1591-1594
58. Gran J.T., Husby G., and Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Annals of the Rheumatic Diseases 44 (1985) 359-367
59. Kaipiainen-Seppanen O., Aho K., and Heliovaara M. Incidence and prevalence of ankylosing spondylitis in Finland. The Journal of Rheumatology 24 (1997) 496-499
60. Gomor B., Gyodi E., and Bakos L. Distribution of HLA B27 and ankylosing spondylitis in the Hungarian population. The Journal of Rheumatology 3 supplement (1977) 33-35
61. Yenal O., Usman O.N., Yassa K., et al. Epidemiology of rheumatic syndromes in Turkey. III. Incidence of rheumatic sacro-iliitis in men of 20-22 years. Zeitschrift fur Rheumatologie 36 (1977) 294-298
62. Andrianakos A., Trontzas P., Christoyannis F., et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. The Journal of Rheumatology 30 (2003) 1589-1601
63. Bruges-Armas J., Lima C., Peixoto M.J., et al. Prevalence of spondyloarthritis in Terceira, Azores: a population based study. Annals of the Rheumatic Diseases 61 (2002) 551-553
64. Saraux A., Guedes C., Allain J., et al. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest. The Journal of Rheumatology 26 (1999) 2622-2627
65. Carter E.T., McKenna C.H., Brian D.D., and Kurland L.T. Epidemiology of ankylosing spondylitis in Rochester, Minnesota, 1935-1973. Arthritis and Rheumatism 22 (1979) 365-370
66. Lawrence R.C., Helmick C.G., Arnett F.C., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis and Rheumatism 41 (1998) 778-799
67. Boyer G.S., Templin D.W., Cornoni-Huntley J.C., et al. Prevalence of spondyloarthropathies in Alaskan Eskimos. The Journal of Rheumatology 21 (1994) 2292-2297
68. Bardin T., and Lathrop G.M. Postvenereal Reiter's syndrome in Greenland. Rheumatic Diseases Clinics of North America 18 (1992) 81-93
69. Khan M.A. Epidemiology of HLA-B27 and arthritis. Clinical Rheumatology 15 supplement 1 (1996) 10-12
70. Cardiel M.H., and Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clinical and Experimental Rheumatology 20 (2002) 617-624
71. Lopez-Larrea C., Gonzalez-Roces S., Pena M., et al. Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Human Immunology 43 (1995) 174-180
72. Hukuda S., Minami M., Saito T., et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan ankylosing spondylitis society. The Journal of Rheumatology 28 (2001) 554-559
73. Yamaguchi A., Tsuchiya N., Mitsui H., et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis and Rheumatism 38 (1995) 1672-1677
74. Yamaguchi A., Ogawa A., Tsuchiya N., et al. HLA-B27 subtypes in Japanese with seronegative spondyloarthropathies and healthy controls. The Journal of Rheumatology 23 (1996) 1189-1193
75. Dai S.M., Han X.H., Zhao D.B., et al. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. The Journal of Rheumatology 30 (2003) 2245-2251
76. Wigley R.D., Zhang N.Z., Zeng Q.Y., et al. Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. The Journal of Rheumatology 21 (1994) 1484-1490
77. Chou C.T., Pei L., Chang D.M., et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. The Journal of Rheumatology 21 (1994) 302-306
78. Al-Rawi Z.S., Al-Shakarchi H.A., Hasan F., and Thewaini A.J. Ankylosing spondylitis and its association with the histocompatibility antigen HL-A B27: an epidemiological and clinical study. Rheumatology and Rehabilitation 17 (1978) 72-75
79. Davatchi F., Nikbin B., and Ala F. Histocompatibility antigens (HLA) in rheumatic diseases in Iran. The Journal of Rheumatology 3 supplement (1977) 36-38
80. Samangooei S., Hakim S., and Khosravi F. Frequency of HLA-alleles B5, B51 and B27 in patients with Behcet's disease from southwest of Iran. IJMS (2000) 25